Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07393958
Eligibility Criteria:
Inclusion Criteria:
* Women of reproductive age with diagnosed endometriosis stage I, II, or III, according to the American Society for Reproductive Medicine (ASRM) classification.
* Women with a diagnosis of endometriosis confirmed by laparoscopy or, in the absence of laparoscopy, by magnetic resonance imaging (MRI) and/or ultrasound.
* Presence of pelvic pain (VAS \> 4) during the last three months.
* No indication for surgical intervention at the time of inclusion in the study.
* Patients who are able to provide informed consent.
Exclusion Criteria:
* Patients under 18 years of age.
* Use of analgesic or anti-inflammatory pharmacological treatment, except for ibuprofen at doses up to 600 mg/day or naproxen at doses up to 500 mg/day.
* Surgery within the year prior to inclusion, performed for therapeutic purposes related to the pathology under study.
* Initiation or discontinuation of hormone therapy within the three months prior to inclusion in the study.
* Patients with known allergy or hypersensitivity to Doliral®.
* Pregnant or breastfeeding patients.
* Patients on sick leave: \> 1 year, or With no intention of returning to work, or Undergoing a disability or permanent incapacity assessment process.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07393958
Study Brief:
Protocol Section:
NCT07393958